Table 2.

MicroRNAs that were significantly differentially expressed between EGFR-mutated compared with wt tumors and between KRAS-mutated compared with wt tumors

	EGFR-mutated vs. wt lung adenocarcinoma tumors
	MicroRNA	FDR	FC1
1	hsa-miR-184	<0.01	5.538
2	hsa-miR-339-3p	<0.01	4.121
3	hsa-miR-148a*	<0.01	3.509
4	hsa-miR-224*	<0.01	5.09
5	hsa-miR-452	<0.01	4.554
6	hsa-miR-450a	<0.01	5.586
7	hsa-miR-423-3p	<0.01	3.873
8	hsa-miR-654-5p	<0.01	3.768
9	hsa-miR-532-5p	<0.01	1.613
10	hsa-miR-3607-5p	<0.01	4.969
11	hsa-miR-28-3p	<0.01	3.261
12	hsa-miR-30d*	<0.01	3.515
13	hsa-miR-532-3p	<0.01	1.949
14	hsa-miR-500a*	<0.01	1.706
15	hsa-miR-502-3p	<0.01	1.769
16	hsa-miR-605	<0.01	4.133
17	hsa-miR-492	<0.01	−3.466
	KRAS-mutated vs. wt lung adenocarcinoma tumors
1	hsa-miR-371-5p	<0.01	−2.127
2	hsa-miR-564	<0.01	−2.526
3	hsa-miR-100	<0.01	1.573

Abbreviations: FDR, false discovery rate; FC, fold change.

¹EGFR-mutated/EGFR wt or KRAS-mutated/KRAS wt.